Showing results (241-250 of 4,238) with videos related to
Sort By:
Pageof 424
Journal for Immunotherapy of Cancer|August 27, 2020
HITM-SURE: Hepatic immunotherapy for metastases phase Ib anti-CEA CAR-T study utilizing pressure enabled drug deliverySteven C Katz, Ashley E Moody, Prajna Guha, et al.Journal for Immunotherapy of Cancer|August 5, 2020
Impact of body composition on outcomes from anti-PD1 +/- anti-CTLA-4 treatment in melanomaArissa C Young, Henry T Quach, Haocan Song, et al.Journal for Immunotherapy of Cancer|August 6, 2020
Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non-small cell lung cancer and a poor performance statusJoao V Alessi, Biagio Ricciuti, Elizabeth Jiménez-Aguilar, et al.Journal for Immunotherapy of Cancer|August 8, 2020
Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancerEva Crespo-Rodriguez, Katharina Bergerhoff, Galabina Bozhanova, et al.Journal for Immunotherapy of Cancer|April 18, 2023
Naive T cells inhibit the outgrowth of intractable antigen-activated memory T cells: implications for T-cell immunotherapySandhya Sharma, Mae Woods, Naren U Mehta, et al.Journal for Immunotherapy of Cancer|April 18, 2023
BRD4 inhibition impairs DNA mismatch repair, induces mismatch repair mutation signatures and creates therapeutic vulnerability to immune checkpoint blockade in MMR-proficient tumorsYu Fu, Bin Yang, Yaoyuan Cui, et al.Journal for Immunotherapy of Cancer|April 18, 2023
Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancerMiao He, Qihua He, Xiuyu Cai, et al.Journal for Immunotherapy of Cancer|April 18, 2023
Barriers to immune cell infiltration in tumorsMarit M Melssen, Natasha D Sheybani, Katie M Leick, et al.Journal for Immunotherapy of Cancer|March 31, 2021
Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB-IVM1c melanomaJosep Malvehy, Igor Samoylenko, Dirk Schadendorf, et al.Journal for Immunotherapy of Cancer|April 1, 2021
Complement C3a and C5a receptor blockade modulates regulatory T cell conversion in head and neck cancerJacob Gadwa, Thomas E Bickett, Laurel B Darragh, et al.Pageof 424